Journal Information
Vol. 14. Issue 6.
Pages 594-600 (November - December 2010)
Share
Share
Download PDF
More article options
Vol. 14. Issue 6.
Pages 594-600 (November - December 2010)
Original article
Open Access
Assessment of the effectiveness of a home-based care program for patients coinfected with tuberculosis and human immunodeficiency virus after discharge from a reference hospital in South-Eastern Brazil
Visits
2709
Carlos Alessandro Plá Bento1,
Corresponding author
plabento@uol.com.br

Correspondence to: Hospital Eduardo de Menezes, Rua Dr. Cristiano Resende, 2213 – Bonsucesso, 30622-020, Belo Horizonte, MG, Brazil. Fax: 55 31 3328 5029.
, Enio Roberto Pietra Pedroso2
1 Master's Degree in Tropical Medicine at Health Science's (Infectology and Tropical Medicine) Postgraduate Course by the Medicine School of Universidade Federal de Minas Gerais. Hospital Eduardo de Menezes (HEM) - Fundação Hospitalar do Estado de Minas Gerais (FHEMIG), Belo-Horizonte, MG, Brazil
2 Full Professor at Departamento de Clínica Médica of the Medicine School of Universidade Federal de Minas Gerais - Centro de Pós-Graduação em Medicina Tropical da Faculdade de Medicina da Universidade Federal de Minas Gerais (FM-UFMG), Belo-Horizonte, MG, Brazil
This item has received

Under a Creative Commons license
Article information
Abstract

The effectiveness of tuberculosis treatment delivered by a home-based care program to patients coinfected with HIV was compared with that of a service provided by outpatient departments. A retrospective study was made of a cohort of coinfected patients discharged from hospital between January 1998 and December 2002 who had been followed-up for one year within one of these programs. Two-hundred-and-forty-three patients who met the inclusion criteria were grouped according to their treatment program (group 1 received home-based care; group 2 attended outpatient departments) and then paired one-to-one across the groups by gender, age and level of education. Only 48 patients from each group could be paired. Apart from the duration of HIV infection, there were no statistically significant differences (P < 0.05) between patients in the two groups with respect to social-demographic status and clinical or laboratory characteristics. In group 1, 75.0% of patients attained successful tuberculosis treatment compared with 72.9% of those in group 2 (P = 0.816). Treatment was abandoned by 22.9% of patients in group 1 and by 54.2% of those in group 2 (P = 0.008). The death rate within one year after discharge was 20.8% for group 1 compared with 6.3% for group 2 (P = 0.334). Although both programs achieved a similar success rate in the treatment of tuberculosis, patients receiving outpatient care were three to eight-times more likely to abandon the program. The importance of assigning patients at-risk of abandoning treatment to a home-based care program after discharge from hospital is emphasized.

Keywords:
AIDS
tuberculosis
treatment outcome
adherence to treatment
home-based care
Full text is only aviable in PDF
References
[1.]
Secretaria de Assistência à Saúde. Programa Nacional de DST/AIDS. Co-infecção TB/HIV/AIDS. Brasília: Ministério da Saúde, 1994. 20 p.
[2.]
P. Farmer, F. Leandre, J. Mukherjee, R. Gupta, L. Tarter, J.Y. Kim.
City-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).
Bull World Health Org, 79 (2001), pp. 1145-1151
[3.]
S. Pushpananthan, J.D. Walley, J. Wright.
Tuberculosis in Swaziland: a health needs assessment in preparation for a community-based program.
Trop Doctor, 30 (2000), pp. 216-220
[4.]
M.F. de Albuquerque, S.C. Albuquerque, A.R. Campelo, et al.
Radiographic features of pulmonary tuberculosis in patients infected by HIV: is there an objective indicator of co-infection?.
Rev Soc Bras Med Trop, 34 (2001), pp. 369-372
[5.]
D. Bleed, C. Dye, M.C. Raviglione.
Dynamics and control of global tuberculosis epidemic.
Curr Opinion Pulm Med, 6 (2000), pp. 74-79
[6.]
R.E. Chaisson, N.A. Martinson.
Tuberculosis in Africa – Combating an HIV-Driven Crisis.
N Engl J Med, 358 (2008), pp. 1089-1092
[7.]
M.A. Hijjar, M.J. Procópio, L.M.R. Freitas, R. Guedes, E.P. Bethlem.
Epidemiology of tuberculosis in the world, Brazil and Rio de Janeiro.
Pulmão RJ, 14 (2005), pp. 310-314
[8.]
A.L. Bierrenbach, A.B.F. Gomes, E.F. Noronha, M.F.M. de Souza.
Tuberculosis incidence and cure rates, Brazil, 2000–2004.
Rev Saúde Pública, 41 (2007), pp. 24-33
[9.]
World Health Organization. An expanded DOTS Framework for Effective tuberculosis control: Annex III TB/HIV. [http:// www.who.int/tb/dots/framework Accessed in 26th April 2005].
[10.]
J.R. Ickovics, A. Cameron, R. Zackin, et al.
Consequences and determinants of adherence to antiretroviral medication: results from adult AIDS trial group protocol 370.
Antiretroviral Ther, 7 (2002), pp. 185-193
[11.]
V.E. Stone.
Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.
Clin Infect Dis, 33 (2001), pp. 865-872
[12.]
J.A. Mitty, T. Flaningan.
Community-based interventions for marginalized populations.
Clin Infect Dis, 38 (2004), pp. 373-375
[13.]
J.A. Mitty, V.E. Stone, M. Sands, G. Macalino, T. Flaningan.
Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress.
Clin Infect Dis, 34 (2002), pp. 984-990
[14.]
Manual de diretrizes técnicas para elaboração e implantação de programas de prevenção e assistência das DST/AIDS no local de trabalho. Brasília: Ministério da Saúde, 1998. 213 p.
[15.]
E.L. Corbett, C.J. Watt, N. Walker, et al.
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.
Arch Int Med, 163 (2003), pp. 1009-1021
[16.]
S. Miti, V. Mfungwe, P. Reijer, D. Maher.
Integration of tuberculosis treatment in a community-based care program for persons living with HIV/AIDS in Ndola. Zambia.
Int J Tuberculosis Lung Dis, 7 (2003), pp. S92-S98
[17.]
Diagnóstico sorológico da infecção pelo HIV. Portaria 488 de 17 de junho de 1998. Brasília: Ministério da saúde.[http://www.aids.gov.br. Accessed in 20th March 2001].
[18.]
A.R. Hill, V.M. Manikal, P.F. Riska.
Effectiveness of directly observed therapy (DOT) for tuberculosis: a review of multinational experience reported in 1990–2000.
Medicine, 81 (2002), pp. 179-193
[19.]
Bento CAP. Estudo do papel da intervenção de serviço de Assistência Domiciliar para pacientes co-infectados por HIV/TB recém desospitalizados de hospital referência em Belo Horizonte – MG sobre a interrupção das terapias anti-retroviral e tuberculostática. Dissertação (Mestrado). 2006. UFMG. Faculdade de Medicina.
[20.]
F.J. Palella Junior, K.M. Delaney, A.C. Moorman, et al.
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.
New Eng J Med, 338 (1998), pp. 853-860
[21.]
N.A. Atomiya, D.E. Uip, O.H. Leite.
Evaluation of disease patterns, treatment and prognosis of tuberculosis in AIDS patients.
Braz J Infect Dis, 6 (2002), pp. 29-39
[22.]
M. Maruza, R. Ximenes, H. Lacerda.
Desfecho do tratamento e confirmação laboratorial do diagnostic de tuberculose em pacientes com HIV/AIDS no Recife, Pernambuco, Brasil.
J Bras Pneumol, 34 (2008), pp. 394-403
[23.]
H. de Oliveira, L. Marin-León, J. Gardinali.
Análise do programa de controle da tuberculose em relação ao tratamento, em Campinas – SP.
J Bras Pneumol, 31 (2005), pp. 133-138
[24.]
L. Diniz, D. Garrett, G. Gerhardt.
Resultados do tratamento de tuberculose em capitais brasileiras – 2002.
Bol Pneumol Sanit, 14 (2006), pp. 71-84
[25.]
P. Kamolraratanakul, H. Sawert, S. Lertmaharit, et al.
Randomized trolled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand.
Trans Royal Soc Trop Med Hygiene, 93 (1999), pp. 552-557
[26.]
A.J. Rodger, M. Toole, B. Lalnuntluangi, V. Muana, P. Deutschmann.
DOTS-based tuberculosis treatment and control during civil conflict and HIV epidemic. Churachandpur District. India.
Bull World Health Organ, 80 (2002), pp. 451-456
[27.]
China tuberculosis control collaboration.
Results of directly observed short-course chemotherapy in 112.842 Chinese patients with smear-positive tuberculosis.
Lancet, 347 (1996), pp. 358-362
[28.]
E. Maciel, A. Silva, W. Meireles, K. Fiorotti, D. Hadad, R. Dietze.
Tratamento supervisionado em pacientes portadores de tuberculose utilizando supervisores domiciliares em Vitória, Brasil.
J Bras Pneumol, 34 (2008), pp. 506-513
[29.]
Gabardo B..
Avaliação da Efetividade do tratamento supervisionado no controle da tuberculose pulmonar bacilífera em Curitiba – PR.
Bol Pneumol Sanit, 14 (2006), pp. 91-97
[30.]
C.E Gazetta, S.H.F. Vendramini, A. Ruffino-Netto, M.R.C. Oliveira, T.C.S. Villa.
Estudo descritivo sobre a implantação da estratégia de tratamento de curta duração diretamente observado controle da tuberculose em São José do Rio Preto e seus impactos (1998–2003).
J Bras Pneumolol, 33 (2007), pp. 192-198
[31.]
A.B. Falcão.
Estudo comparativo do tratamento supervisionado da tuberculose com o auto-administrado.
Bol Pneumolol Sanit, 14 (2006), pp. 21-25
[32.]
World Health Organization Global Tuberculosis Program. Treatment of tuberculosis: guidelines for national programs. 2nd ed. WHO/TB/97.220. Geneva: World Health Organization, 1997.
[33.]
W. Wobeser, L. Yuan, M. Naus.
Outcome of pulmonary tuberculosis treatment in the tertiary care setting-Toronto 1992/93. Tuberculosis treatment completion study group.
CMAJ, 160 (1999), pp. 789-794
[34.]
T.V. Penerger, P. Sudre, J.D. Lundgren, B. Hirschel.
Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study Group.
BMJ, 311 (1995), pp. 1468-1471
[35.]
C.A. Liechty, D.R. Bangsberg.
Doubts about DOT: Antiretroviral therapy for resource-poor countries.
[36.]
F.L. Altice, F. Mostashari, G.H. Friedland.
Trust and acceptance of and adherence to antiretroviral therapy.
J Acquir Immune Defic Syndr, 28 (2001), pp. 47-58
[37.]
D.L. Peterson, S. Swindells, J. Mohr, et al.
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.
Ann Intern Med, 133 (2000), pp. 21-30
[38.]
A.D. Harries, N.J. Hargreaves, R. Chimzizi, F.M. Salaniponi.
Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
Bull World Health Organ, 80 (2002), pp. 464-469
[39.]
D.R. Bangsberg, L.M. Mundry, J.P. Tulsky.
Expanding DOT tuberculosis to human immunodeficiency virus.
Am J Med, 110 (2001), pp. 664-666
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
The Brazilian Journal of Infectious Diseases
Article options
Tools